MedPath

Teres Major Muscle and Subacromial Impingement Syndrome

Not Applicable
Conditions
Subacromial Impingement Syndrome
Trigger Points in Teres Major Muscle
Interventions
Device: Diacutaneous Fibrolysis
Other: Trigger Point Pressure Release
Other: Protocolized physiotherapy
Registration Number
NCT02374125
Lead Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Brief Summary

There is not a clear understanding of the origin of symptoms perceived by patients with impingement of the soft tissue structures of the subacromial space. Tendinopathy, tendon rupture or other pathologies, are present in asymptomatic subjects and subjects with symptoms and structural integrity can also be found.

Patients diagnosed with subacromial impingement syndrome frequently have myofascial trigger points in the teres major muscle. Travell and Simons reported that the symptoms caused by trigger points in this muscle are similar to those experienced by patients diagnosed with impingement syndrome, but a literature search provides few results regarding relationship between subacromial impingement syndrome and presence of myofascial trigger points in the teres major muscle.

This study aims to provide evidence of the results that can be obtained with a specific approach of teres mayor muscle by two manual techniques, Trigger Point Pressure Release and Diacutaneous Fibrolysis, in subjects with subacromial impingement syndrome, a condition that still representing both a diagnostic and therapeutic challenge. Secondary objective is to compare the outcomes between both techniques to select for each patient the most appropriate to their needs and characteristics.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Age 18 years and over
  • Clinical diagnosis of Subacromial Impingement Syndrome.
  • Detectable trigger points in teres major muscle.
  • Sign informed consent form.
Exclusion Criteria
  • Diacutaneous Fibrolysis contraindications
  • Previous shoulder surgery (<1year)
  • Language barriers or cognitive issues that limit their ability to provide informed consent and participate in research.
  • Patients with a pending litigation or court claim.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fibrolysis GroupDiacutaneous FibrolysisActual Diacutaneous Fibrolysis and protocolized physiotherapy
Fibrolysis GroupProtocolized physiotherapyActual Diacutaneous Fibrolysis and protocolized physiotherapy
Pressure GroupProtocolized physiotherapyTrigger Point Pressure Release and protocolized physiotherapy
Pressure GroupTrigger Point Pressure ReleaseTrigger Point Pressure Release and protocolized physiotherapy
Control GroupProtocolized physiotherapyProtocolized physiotherapy
Primary Outcome Measures
NameTimeMethod
Change in Pain intensity (Using a VAS)Change from baseline to 3 weeks.

Using a VAS

Change in Functional capacity (Abbreviated Constant-Murley score)Change from baseline to 3 weeks.

Abbreviated Constant-Murley score

Secondary Outcome Measures
NameTimeMethod
Change in Active Range of MotionChange from baseline to 3 weeks.

Flexion, extension, abduction, external rotation and internal rotation

Patient perception of change (Global Rating of Change scale)3 weeks after recruitment

Global Rating of Change scale

Trial Locations

Locations (1)

Catalan Health Institut. Sant Ildefons Rehabilitation Service

🇪🇸

Cornellà de Llobregat, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath